TAIPEI, May 22, 2023 /PRNewswire/ -- Meet SINBON Electronics at EUROBIKE 2023 Germany ...

SEOUL, South Korea, Nov. 24, 2025 /PRNewswire/ -- The WORLD HYDROGEN EXPO 2025 ("WHE 2025"), set to become the world's largest hydrogen industry exhibition, will be held for four days from Wednesday, ...

Hollysys Automation Technologies Reports Unaudited Financial Results for the Second Quarter and the First Half Year Ended December 31, 2023 First Half of Fiscal Year 2024 Financial Highlights * Total ...

Tomas Hruska, Managing Director of L'Oréal Singapore, said "With science as one of our foundational pillars, L'Oréal is dedicated to fostering the potential of girls and women in STEM fields. Our ...

HAIKOU, China, Dec. 30, 2023 /PRNewswire/ -- China's first national parks were officially established two years ago in October 2023. The documentary "China's Hainan: Song of the Rainforest" gives ...

FWD Group is a pan-Asian life and health insurance business that serves approximately 30 million customers across 10 markets, including BRI Life in Indonesia. FWD's customer-led and digitally enabled ...

SINGAPORE, Jan. 21, 2025 /PRNewswire/ -- The Marketing Society proudly announces key leadership updates within its Singapore hub as the organisation continues to strengthen its commitment to empower ...

LONGi Chairman Zhong Baoshen Spoke at Davos 2025 Conference: Global Cooperation Will Accelerate the Adoption of Photovoltaic Technology, Empowering Humanity to Achieve Energy Equity DAVOS, Switzerland ...

Tasting Culture and Enhancing Communication: Guiyang Confucius Academy Shares Wang Yangming's Study of the Mind with the World GUIYANG, China, July 31, 2025 /PRNewswire/ -- A news report by ...

Methodology QS use a unique methodology to calculate this ranking. The methodology is designed to account for the unique challenges facing the region's universities, and features 10 indicators. They ...

HONG KONG, May 13, 2026 /PRNewswire/ -- TENCENT ANNOUNCES 2026 FIRST QUARTER RESULTS ...

Minghui Pharmaceutical Inc. Announces Phase 2 Clinical Trial Success of MH004 Cream as a Potential Best-in-Class Topical Treatment for Mild-to-Moderate Atopic Dermatitis and the FDA Clearance of its ...